Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.

Liu Y, Pérez M, Aft RL, Massman K, Robinson E, Myles S, Schootman M, Gillanders WE, Jeffe DB.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):675-80. doi: 10.1158/1055-9965.EPI-09-1051. Epub 2010 Feb 16. Erratum in: Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1661.

2.

A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.

Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Ellis MJ, Jeffe DB.

Breast Cancer Res Treat. 2010 Dec;124(3):835-44. doi: 10.1007/s10549-010-0912-1. Epub 2010 May 6.

3.

Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.

Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB.

Breast Cancer Res Treat. 2011 Nov;130(1):165-73. doi: 10.1007/s10549-011-1551-x. Epub 2011 May 8.

4.

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.

Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.

J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.

5.

Perception of cancer recurrence risk: more information is better.

Kelly KM, Ajmera M, Bhattacharjee S, Vohra R, Hobbs G, Chaudhary L, Abraham J, Agnese D.

Patient Educ Couns. 2013 Mar;90(3):361-6. doi: 10.1016/j.pec.2011.12.003. Epub 2012 Jan 9.

PMID:
22231022
6.

A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.

Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, Pritchard KI, Ho C, Redelmeier DA.

Breast Cancer Res Treat. 2003 Feb;77(3):285-93.

PMID:
12602928
7.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533
8.

Perceptions of contralateral breast cancer: an overestimation of risk.

Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T.

Ann Surg Oncol. 2011 Oct;18(11):3129-36. doi: 10.1245/s10434-011-1914-x. Epub 2011 Sep 27.

PMID:
21947590
9.

Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients.

Waters EA, Liu Y, Schootman M, Jeffe DB.

Ann Behav Med. 2013 Feb;45(1):57-68. doi: 10.1007/s12160-012-9406-1.

10.

Worry about breast cancer recurrence: a population-based analysis.

Tewari A, Chagpar AB.

Am Surg. 2014 Jul;80(7):640-5.

PMID:
24987893
11.

Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study.

Portschy PR, Abbott AM, Burke EE, Nzara R, Marmor S, Kuntz KM, Tuttle TM.

Ann Surg Oncol. 2015 Nov;22(12):3846-52. doi: 10.1245/s10434-015-4442-2. Epub 2015 Mar 12.

PMID:
25762480
12.

Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.

Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP Jr.

Breast Cancer Res. 2009;11(6):R85. doi: 10.1186/bcr2453. Epub 2009 Nov 18.

13.

Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.

[No authors listed]

Prescrire Int. 2013 Dec;22(144):298-303. Review.

PMID:
24600734
14.

A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ.

van Gestel YR, Voogd AC, Vingerhoets AJ, Mols F, Nieuwenhuijzen GA, van Driel OJ, van Berlo CL, van de Poll-Franse LV.

Eur J Cancer. 2007 Feb;43(3):549-56. Epub 2006 Nov 30.

PMID:
17140788
15.

The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.

Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15.

PMID:
9747827
16.
17.

Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.

Hawley ST, Griggs JJ, Hamilton AS, Graff JJ, Janz NK, Morrow M, Jagsi R, Salem B, Katz SJ.

J Natl Cancer Inst. 2009 Oct 7;101(19):1337-47. doi: 10.1093/jnci/djp271. Epub 2009 Aug 31.

18.

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

Boyages J, Delaney G, Taylor R.

Cancer. 1999 Feb 1;85(3):616-28.

PMID:
10091735
19.

Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.

Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A.

Cancer. 2001 May 15;91(10):1862-9.

PMID:
11346867
20.

Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.

Silverstein MJ, Lagios MD, Martino S, Lewinsky BS, Craig PH, Beron PJ, Gamagami P, Waisman JR.

J Clin Oncol. 1998 Apr;16(4):1367-73.

PMID:
9552039
Items per page

Supplemental Content

Write to the Help Desk